Ewa Wrona

6PUBLICATIONS
32CO-AUTHORS
Innate immunityCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 09, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Jooho Chung, Mounica Vallurupalli, Sarah Noel

|Jun 19, 2024
Permanent and Persistent Atrial Fibrillations Are Independent Risk Factors of Mortality after Severe COVID-19.

Agnieszka Zając, Ewa Wrona, Jarosław D Kasprzak

|Oct 27, 2022
Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience.

Renata Pacholczak-Madej, Aleksandra Grela-Wojewoda, Mirosława Puskulluoglu

|Jun 02, 2021
CAR-NK Cells in the Treatment of Solid Tumors.

Ewa Wrona, Maciej Borowiec, Piotr Potemski

|Feb 25, 2021
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Ewa Wrona, Piotr Potemski, Francesco Sclafani

|Aug 29, 2019
MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.

Ewa Wrona, Marcin Braun, Agata Pastorczak

Pageof 1